To study the anti-obesity and anti-inflammatory effects of weight loss due to CB1 blockade, we used a well-established DIO intervention model whereby 6-week-old mice were fed HFD or control LFD for 12 weeks to induce an obese or lean phenotype, respectively. The gene discussed is CNR1; the disease is obesity disorder.